Evicenter
Stelara (ustekinumab) in Plaque psoriasis
Manufacturer
Janssen Biotech, Inc.
Prescribing information
Stelara (opens in a new tab)
Questions
29
Last updated

All questions

Safety: Stelara (ustekinumab) in plaque psoriasis

8 questions · 3 sources

Side effects

Do patients develop antibodies to Stelara in plaque psoriasis (immunogenicity)?

Applies to Adults with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy

Note: The 6 to 12.4% range pools the plaque psoriasis and psoriatic arthritis trials; the label gives no separate range for plaque psoriasis.

What are the most common side effects of Stelara for plaque psoriasis?

Which Stelara side effects were more common than placebo in psoriasis trials?

Applies to Adults with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy

Note: Table 9 columns are placebo, STELARA 45 mg, and STELARA 90 mg; the header row places STELARA above the 45 mg and 90 mg columns.

Warnings

Does Stelara increase the risk of serious infections?

Does Stelara increase the risk of cancer?

Do patients need a TB test before starting Stelara?

Safety evidence

How often did infections occur with Stelara in psoriasis trials?

Applies to Adults with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy

What are the long-term side effects of Stelara for psoriasis?

Applies to Adults with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy